Yesterday, Phoenix Copper (LON: PXC) announced that NIU Invest, the 11.7% shareholder, withdrew its requisition notice for a general meeting, but no reason was given. The share price gained 9.09% to 1.2p.
Iodine producer Iofina (LON: IOF) continues its upward momentum following better than expected figures for 2025 and upgrades to future years. A new large iodine plant will start production later this year leading to a big rise in production in 2027. More plants are in the pipeline. X-ray demand for iodine is keeping the price high and Canaccord is anticipating it staying above $70/tonne. The share price rose a further 2.565 to 40p, having been as high as 41.5p.
Atome (LON: ATOM) finance director Robert Sheffrin bought 33,147 shares at 60p each. This follows his subscription of 57,482 shares in the recent fundraising at 60p/share. The share price improved 4.13% to 63p.
FALLERS
GenIP (LON: GNIP) is raising £350,000 at 7p/share and the cash will be used to fund new product development and additional staff. CMC has been appointed as joint broker. The share price declined by two-fifths to 6.75p.
ADM Energy (LON: ADME) is raising £375,000 at 0.02p/share. The cash will be spent on increasing the interest in Vega Upstream JV to 35%. That should increase monthly revenues by $111,000. Another 375 million shares are being issued to pay creditors. Capital Plus Partners has been appointed broker. The share price fell 14.3% to 0.03p.
ProService Building Services Marketplace (LON: PRO), formerly HSS Hire, says 2025-26 revenues from continuing operations is expected to be £248m, which is lower than forecast. That is due to a lower ramping up of the new arrangements with Speedy Hire and the weak construction market. The company is investing in further automation of its marketplace platform. Speedy Hire volumes are improving, and the deal should be earnings enhancing this year. Net debt was £27.2m at the end of March 2026 and debt should be refinanced by August. Guidance for 2026-27 EBITDA is between £9m and £12m. Consensus was previously £19.6m. The share price dipped 12.15 to 3.395p.
Shield Therapeutics (LON: STX) generated revenues of $18m in the first quarter of 2026 with ACCRUFeR making $9.9m and a $7.9m milestone payment from China. The US sales continue to grow, but NY-Medicaid now requires prior authorisation for prescription approvals. The share price slid 13.15 to 7.6p.
Mkango Resources (LON: MKA) has filed a technical report under NI 43-101 definitive feasibility study report for the Songwe Hill rare earths project in Malawi. Songwe Hill’s post-tax NPV10 is $339m and payback is 3.4 years. There was cash of $3.1m at the end of 2025 and subsequently raised £11.7m at 33p/share. The share price is 5.38% lower at 44p.